Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Diagnostic Imaging

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    February 2018
  1. TANADINI-LANG S, Bogowicz M, Veit-Haibach P, Huellner M, et al
    Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer.
    Anticancer Res. 2018;38:685-690.
    PubMed     Text format     Abstract available


  2. LUCZYNSKA E, Niemiec J, Heinze S, Adamczyk A, et al
    Intensity and Pattern of Enhancement on CESM: Prognostic Significance and its Relation to Expression of Podoplanin in Tumor Stroma - A Preliminary Report.
    Anticancer Res. 2018;38:1085-1095.
    PubMed     Text format     Abstract available


  3. HORTON CE, Kamal M, Leslie M, Zhang R, et al
    Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans.
    Anticancer Res. 2018;38:1073-1076.
    PubMed     Text format     Abstract available


  4. HAUSMANN D, Liu J, Budjan J, Reichert M, et al
    Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s(2)) DWI for Response Assessment in Rectal Cancer.
    Anticancer Res. 2018;38:969-978.
    PubMed     Text format     Abstract available


    January 2018
  5. MIRKA H, Baxa J, Hora M, Hes O, et al
    Iodine Content Analysis Using Dual-Energy Computed Tomography as a Biomarker of Transitional Cell Carcinoma, an Experience with Separation of the Clotted Blood and Tumorous Tissue.
    Anticancer Res. 2018;38:541-545.
    PubMed     Text format     Abstract available


  6. SERTDEMIR M, Weidner AM, Schoenberg SO, Morelli JN, et al
    Is There a Role for Functional MRI for the Assessment of Extracapsular Extension in Prostate Cancer?
    Anticancer Res. 2018;38:427-432.
    PubMed     Text format     Abstract available


  7. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Text format     Abstract available


  8. NAKUZ TS, Berger E, El-Rabadi K, Wadsak W, et al
    Clinical Value of (18)F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma.
    Anticancer Res. 2018;38:353-358.
    PubMed     Text format     Abstract available


  9. KISHIMOTO S, Aoki H, Suzuki R, Inoue M, et al
    Angiographic Evaluation of Vascular Damage in Rat Liver After Administration of Epirubicin or Miriplatin.
    Anticancer Res. 2018;38:247-251.
    PubMed     Text format     Abstract available


  10. KIYUNA T, Tome Y, Uehara F, Murakami T, et al
    Tumor-targeting Salmonella typhimurium A1-R Inhibits Osteosarcoma Angiogenesis in the In Vivo Gelfoam(R) Assay Visualized by Color-coded Imaging.
    Anticancer Res. 2018;38:159-164.
    PubMed     Text format     Abstract available


  11. SOTTERO TL, Girard EJ, Myers C, Hopping G, et al
    Pacifastin-derived Peptides Target Tumors for Use in In Vivo Imaging.
    Anticancer Res. 2018;38:51-60.
    PubMed     Text format     Abstract available


  12. CHANG LW, Hung SC, Hu JC, Chiu KY, et al
    Retzius-sparing Robotic-assisted Radical Prostatectomy Associated with Less Bladder Neck Descent and Better Early Continence Outcome.
    Anticancer Res. 2018;38:345-351.
    PubMed     Text format     Abstract available


    December 2017
  13. TAKADA K, Toyokawa G, Tagawa T, Kohashi K, et al
    Association Between PD-L1 Expression and Metabolic Activity on (18)F-FDG PET/CT in Patients with Small-sized Lung Cancer.
    Anticancer Res. 2017;37:7073-7082.
    PubMed     Text format     Abstract available


  14. MIRKA H, Tupy R, Narsanska A, Hes O, et al
    Pre-surgical Multiparametric Assessment of Breast Lesions Using 3-Tesla Magnetic Resonance.
    Anticancer Res. 2017;37:6965-6970.
    PubMed     Text format     Abstract available


  15. HOFFMANN MA, Taymoorian K, Ruf C, Gerhards A, et al
    Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.
    Anticancer Res. 2017;37:6871-6877.
    PubMed     Text format     Abstract available


  16. AULA H, Skytta T, Tuohinen S, Luukkaala T, et al
    Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study.
    Anticancer Res. 2017;37:6815-6824.
    PubMed     Text format     Abstract available


  17. ERBER R, Stohr R, Herlein S, Giedl C, et al
    Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer(R) Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer.
    Anticancer Res. 2017;37:6771-6778.
    PubMed     Text format     Abstract available


    October 2017

  18. Applications of Mass Spectrometry Imaging to Cancer, Volume 134. 1st Edition.
    Anticancer Res. 2017;37:5908.
    PubMed     Text format    


  19. ANGELOPOULOU MK, Mosa E, Pangalis GA, Rondogianni P, et al
    The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.
    Anticancer Res. 2017;37:5727-5736.
    PubMed     Text format     Abstract available


  20. MORINE Y, Enkhbold C, Imura S, Ikemoto T, et al
    Accurate Estimation of Functional Liver Volume Using Gd-EOB-DTPA MRI Compared to MDCT/99mTc-SPECT Fusion Imaging.
    Anticancer Res. 2017;37:5693-5700.
    PubMed     Text format     Abstract available


  21. RATHMANN N, Kara K, Budjan J, Henzler T, et al
    Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Anticancer Res. 2017;37:5681-5685.
    PubMed     Text format     Abstract available


  22. BAKALOVA R, Zhelev Z, Shibata S, Nikolova B, et al
    Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Versus "Onco-Suppressive" Reactive Oxygen Species.
    Anticancer Res. 2017;37:5449-5458.
    PubMed     Text format     Abstract available


  23. GIGLI S, Amabile MI, DI Pastena F, DE Luca A, et al
    Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature.
    Anticancer Res. 2017;37:5395-5398.
    PubMed     Text format     Abstract available


  24. ANGELIERI F, Yujra VQ, Oshima CTF, Ribeiro DA, et al
    Do Dental X-Rays Induce Genotoxicity and Cytotoxicity in Oral Mucosa Cells? A Critical Review.
    Anticancer Res. 2017;37:5383-5388.
    PubMed     Text format     Abstract available


    September 2017
  25. THEODORE C, Levaillant JM, Capmas P, Chabi N, et al
    MRI and Ultrasound Fusion Imaging for Cervical Cancer.
    Anticancer Res. 2017;37:5079-5085.
    PubMed     Text format     Abstract available


  26. EICHLER C, Abrar S, Puppe J, Arndt M, et al
    Detection of Ductal Carcinoma In Situ by Ultrasound and Mammography: Size-dependent Inaccuracy.
    Anticancer Res. 2017;37:5065-5070.
    PubMed     Text format     Abstract available


  27. WU X, Reinikainen P, Kapanen M, Vierikko T, et al
    Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
    Anticancer Res. 2017;37:5027-5032.
    PubMed     Text format     Abstract available


  28. WIKSTROM J, Isacsson U, Johansson B, Lennernas BO, et al
    Magnetic Resonance Compatibility of a Transponder Aimed for Radiotherapy Positioning - A Phantom Study.
    Anticancer Res. 2017;37:4993-4996.
    PubMed     Text format     Abstract available


  29. KRAMMER J, Stepniewski K, Kaiser CG, Brade J, et al
    Value of Additional Digital Breast Tomosynthesis for Preoperative Staging of Breast Cancer in Dense Breasts.
    Anticancer Res. 2017;37:5255-5261.
    PubMed     Text format     Abstract available


    August 2017
  30. WANG Y, Li D, Liu R, Jia C, et al
    Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 Stage Laryngeal and Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:4563-4567.
    PubMed     Text format     Abstract available


  31. YUAN Z, Qu X, Zhang ZT, Jiang WG, et al
    Application of Localization and Needle Placement Guided by Mammographic, Ultrasound and Fiberoptic Ductoscopy for Resection of Non-palpable Breast Lesions.
    Anticancer Res. 2017;37:4523-4527.
    PubMed     Text format     Abstract available


  32. TANG K, Sui LL, Xu G, Zhang T, et al
    Effects of Different Palliative Jaundice Reducing Methods on Immunologic Functions in Patients with Advanced Malignant Obstructive Jaundice.
    Anticancer Res. 2017;37:4665-4670.
    PubMed     Text format     Abstract available


  33. JIN L, Zhu L, Li S, Zeng Y, et al
    Predictors of Malignancy for Female Patients with Suspicious Nipple Discharge: A Retrospective Study.
    Anticancer Res. 2017;37:4655-4658.
    PubMed     Text format     Abstract available


  34. DONG W, Li B, Wang J, Song Y, et al
    Exploration of the Radiotherapeutic Clinical Target Volume Delineation for Gastric Cancer from Lymph Node Metastases.
    Anticancer Res. 2017;37:4629-4634.
    PubMed     Text format     Abstract available


    July 2017
  35. HASEGAWA K, Suetsugu A, Nakamura M, Matsumoto T, et al
    Imaging the Role of Multinucleate Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in Peritoneal Metastasis in Mouse Models.
    Anticancer Res. 2017;37:3435-3440.
    PubMed     Text format     Abstract available


  36. SUROV A, Meyer HJ, Wienke A
    Correlation Between Minimum Apparent Diffusion Coefficient (ADCmin) and Tumor Cellularity: A Meta-analysis.
    Anticancer Res. 2017;37:3807-3810.
    PubMed     Text format     Abstract available


  37. MESCHER C, Ding C, Defor T, Konety S, et al
    Left Ventricular Ejection Fraction Screening and Clinical Decision-making in Metastatic HER2-positive Breast Cancer.
    Anticancer Res. 2017;37:3751-3755.
    PubMed     Text format     Abstract available


    June 2017
  38. PEPE P, Garufi A, Priolo GD, Pennisi M, et al
    Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach.
    Anticancer Res. 2017;37:3291-3294.
    PubMed     Text format     Abstract available


  39. FITZPATRICK C, Lynch O, Marignol L
    68Ga-PSMA-PET/CT Has a Role in Detecting Prostate Cancer Lesions in Patients with Recurrent Disease.
    Anticancer Res. 2017;37:2753-2760.
    PubMed     Text format     Abstract available


  40. SCHERZ A, Feller K, Berezowska S, Genitsch V, et al
    Successful Treatment of Pituitary Germinoma with Etoposide, Cisplatin, Vincristine, Methotrexate and Bleomycin Chemotherapy Without Radiotherapy.
    Anticancer Res. 2017;37:3111-3115.
    PubMed     Text format     Abstract available


    May 2017
  41. KOLLA BC, Roy SS, Duval S, Weisdorf D, et al
    Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends.
    Anticancer Res. 2017;37:2445-2449.
    PubMed     Text format     Abstract available


  42. PRESL J, Ovesna P, Novotny Z, Vlasak P, et al
    Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.
    Anticancer Res. 2017;37:2697-2702.
    PubMed     Text format     Abstract available


  43. EISTERER W, Piringer G, DE Vries A, Ofner D, et al
    Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
    Anticancer Res. 2017;37:2683-2691.
    PubMed     Text format     Abstract available


  44. KIM JY, Na K, Kim HS
    Clinicopathological Characteristics of Mitotically-active Cellular Fibroma of the Ovary: A Single-institutional Experience.
    Anticancer Res. 2017;37:2557-2564.
    PubMed     Text format     Abstract available


  45. MANDELKOW R, Gumbel D, Ahrend H, Kaul A, et al
    Detection and Quantification of Nuclear Morphology Changes in Apoptotic Cells by Fluorescence Microscopy and Subsequent Analysis of Visualized Fluorescent Signals.
    Anticancer Res. 2017;37:2239-2244.
    PubMed     Text format     Abstract available


    April 2017
  46. KAISER CG, Herold M, Krammer J, Baltzer P, et al
    Prognostic Value of "Prepectoral Edema" in MR-mammography.
    Anticancer Res. 2017;37:1989-1995.
    PubMed     Text format     Abstract available


  47. HARADA N, Yoshizumi T, Maeda T, Kayashima H, et al
    Preoperative Pancreatic Stiffness by Real-time Tissue Elastography to Predict Pancreatic Fistula After Pancreaticoduodenectomy.
    Anticancer Res. 2017;37:1909-1915.
    PubMed     Text format     Abstract available


    March 2017

  48. Oncologic Imaging: Urology.
    Anticancer Res. 2017;37:1544.
    PubMed     Text format    


  49. TOYOKAWA G, Takada K, Okamoto T, Kozuma Y, et al
    Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer.
    Anticancer Res. 2017;37:1393-1401.
    PubMed     Text format     Abstract available


  50. D'ONOFRIO M, Cingarlini S, Ortolani S, Crosara S, et al
    Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.
    Anticancer Res. 2017;37:1305-1311.
    PubMed     Text format     Abstract available


  51. HENKENBERENS C, VON Klot CA, Ross TL, Bengel FM, et al
    68Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic Therapy.
    Anticancer Res. 2017;37:1273-1279.
    PubMed     Text format     Abstract available


  52. SCIALPI M, Prosperi E, D'Andrea A, Martorana E, et al
    Biparametric versus Multiparametric MRI with Non-endorectal Coil at 3T in the Detection and Localization of Prostate Cancer.
    Anticancer Res. 2017;37:1263-1271.
    PubMed     Text format     Abstract available


  53. ELLIS-CALEO T, Hegde JV, Bath S, Mesko S, et al
    Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate Cancer.
    Anticancer Res. 2017;37:1237-1242.
    PubMed     Text format     Abstract available


  54. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    MIC1/GDF15 as a Bone Metastatic Disease Biomarker.
    Anticancer Res. 2017;37:1501-1505.
    PubMed     Text format     Abstract available


  55. LAWSON BO, Khong HT
    Narcoleptic-like Episodes in a Patient Receiving Pegylated Interferon-alpha 2b: A Case Report and Review of Literature.
    Anticancer Res. 2017;37:1365-1368.
    PubMed     Text format     Abstract available


  56. IIZUKA D, Sasatani M, Barcellos-Hoff MH, Kamiya K, et al
    Hydrogen Peroxide Enhances TGFbeta-mediated Epithelial-to-Mesenchymal Transition in Human Mammary Epithelial MCF-10A Cells.
    Anticancer Res. 2017;37:987-995.
    PubMed     Text format     Abstract available


  57. DAI X, Liu D, Liu M, Zhang X, et al
    Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
    Anticancer Res. 2017;37:979-986.
    PubMed     Text format     Abstract available


    February 2017
  58. LIBERALE G, Lecocq C, Garcia C, Muylle K, et al
    Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Anticancer Res. 2017;37:929-934.
    PubMed     Text format     Abstract available


  59. TOYOKAWA G, Kozuma Y, Matsubara T, Haratake N, et al
    Radiological Features of the Surgically Resected Small-sized Small-cell Lung Cancer on Computed Tomography.
    Anticancer Res. 2017;37:877-881.
    PubMed     Text format     Abstract available


  60. SASAKI K, Uchikado Y, Okumura H, Omoto I, et al
    Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2017;37:859-864.
    PubMed     Text format     Abstract available


  61. SALMINEN E, Niiniviita H, Jarvinen H, Heinavaara S, et al
    Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.
    Anticancer Res. 2017;37:831-834.
    PubMed     Text format     Abstract available


  62. ILENKO A, Sergent F, Mercuzot A, Zitoun M, et al
    Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?
    Anticancer Res. 2017;37:903-907.
    PubMed     Text format     Abstract available


  63. ROSARIO M, Takeuchi A, Yamamoto N, Hayashi K, et al
    Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
    Anticancer Res. 2017;37:749-754.
    PubMed     Text format     Abstract available


  64. KLEIN F, Denecke T, Faber W, Jurgensen C, et al
    DNA Cytometry for Differentiation Between Low- and Medium-grade Dysplasia in Intraductal Papillary Mucinous Neoplasms.
    Anticancer Res. 2017;37:735-740.
    PubMed     Text format     Abstract available


    January 2017
  65. ATTENBERGER UI, Ong MM, Rathmann N, Doyon F, et al
    mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer.
    Anticancer Res. 2017;37:215-222.
    PubMed     Text format     Abstract available


    December 2016
  66. STRANDBERG S, Karlsson CT, Ogren M, Axelsson J, et al
    11C-Acetate-PET/CT Compared to 99mTc-HDP Bone Scintigraphy in Primary Staging of High-risk Prostate Cancer.
    Anticancer Res. 2016;36:6475-6479.
    PubMed     Text format     Abstract available


  67. YAMAGUCHI H, Hori M, Suzuki O, Seo Y, et al
    Clinical Significance of the Apparent Diffusion Coefficient Ratio in Prostate Cancer Treatment with Intensity-modulated Radiotherapy.
    Anticancer Res. 2016;36:6551-6556.
    PubMed     Text format     Abstract available


    November 2016
  68. KOBAYASHI M, Huang CL, Sonobe M, Kikuchi R, et al
    Ad-shWnt2b Vector Therapy Demonstrates Antitumor Activity in Orthotopic Intrapleural Models as Monitored with the In Vitro Imaging System (IVIS).
    Anticancer Res. 2016;36:5887-5893.
    PubMed     Text format     Abstract available


  69. ICHIHARA H, Okumura M, Matsumoto Y
    Therapeutic Effects of Hybrid Liposomes Against Xenograft Mouse Model of Colorectal Cancer In Vivo Due to Long-term Accumulation.
    Anticancer Res. 2016;36:5875-5882.
    PubMed     Text format     Abstract available


    October 2016
  70. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of PET-CT in the Diagnosis and Treatment of Recurrence After Esophageal Cancer Surgery.
    Anticancer Res. 2016;36:5473-5480.
    PubMed     Text format     Abstract available


  71. WALDREP AR, Avery EJ, Rose FF Jr, Midathada MV, et al
    Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy.
    Anticancer Res. 2016;36:5389-5395.
    PubMed     Text format     Abstract available


  72. KLEMENTIEVA NV, Snopova LB, Prodanets NN, Furman OE, et al
    Fluorescence Imaging of Actin Fine Structure in Tumor Tissues Using SiR-Actin Staining.
    Anticancer Res. 2016;36:5287-5294.
    PubMed     Text format     Abstract available


    September 2016
  73. LIBERALE G, Vankerckhove S, Galdon MG, Larsimont D, et al
    Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer.
    Anticancer Res. 2016;36:4853-8.
    PubMed     Text format     Abstract available


  74. PORPIGLIA F, DE Luca S, Passera R, Manfredi M, et al
    Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
    Anticancer Res. 2016;36:4833-9.
    PubMed     Text format     Abstract available


  75. SHIN YR, Kim KA, Im S, Hwang SS, et al
    Prediction of KRAS Mutation in Rectal Cancer Using MRI.
    Anticancer Res. 2016;36:4799-804.
    PubMed     Text format     Abstract available


  76. PROVOST C, Prignon A, Cazes A, Combaret V, et al
    68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
    Anticancer Res. 2016;36:4459-66.
    PubMed     Text format     Abstract available


  77. HASEGAWA K, Suetsugu A, Nakamura M, Matsumoto T, et al
    Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.
    Anticancer Res. 2016;36:4443-8.
    PubMed     Text format     Abstract available


  78. ATANASOVA S, Nikolova B, Murayama S, Stoyanova E, et al
    Electroinduced Delivery of Hydrogel Nanoparticles in Colon 26 Cells, Visualized by Confocal Fluorescence System.
    Anticancer Res. 2016;36:4601-6.
    PubMed     Text format     Abstract available


  79. KHOSRAWIPOUR V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D, et al
    Evaluating the Effect of Micropump(c) Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.
    Anticancer Res. 2016;36:4595-600.
    PubMed     Text format     Abstract available


  80. NISHIMURA M, Murayama Y, Harada K, Kamada Y, et al
    Photodynamic Diagnosis of Hepatocellular Carcinoma Using 5-Aminolevulinic Acid.
    Anticancer Res. 2016;36:4569-74.
    PubMed     Text format     Abstract available


  81. STANKEVICIUS V, Vasauskas G, Noreikiene R, Kuodyte K, et al
    Extracellular Matrix-dependent Pathways in Colorectal Cancer Cell Lines Reveal Potential Targets for Anticancer Therapies.
    Anticancer Res. 2016;36:4559-67.
    PubMed     Text format     Abstract available


  82. MATSUMOTO T, Suetsugu A, Hasegawa K, Nakamura M, et al
    A Mouse Model of Fluorescent Protein-expressing Disseminated Peritoneal Lymphoma for Fluorescence-guided Surgery.
    Anticancer Res. 2016;36:4483-7.
    PubMed     Text format     Abstract available


    August 2016

  83. PET/CT in Neuroendocrine Tumors.
    Anticancer Res. 2016;36:4375-6.
    PubMed     Text format    


  84. LUCZYNSKA E, Heinze S, Adamczyk A, Rys J, et al
    Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Anticancer Res. 2016;36:4359-66.
    PubMed     Text format     Abstract available


  85. ZUGOR V, Kuhn R, Engelhard K, Poth S, et al
    The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
    Anticancer Res. 2016;36:4279-83.
    PubMed     Text format     Abstract available


  86. EL-RABADI K, Weber M, Mayerhofer M, Nakuz T, et al
    Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.
    Anticancer Res. 2016;36:4187-93.
    PubMed     Text format     Abstract available


  87. DE FELICE F, Musio D, Bulzonetti N, Maghella F, et al
    Target Volume Delineation Based on Diffusion-weighted magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2016;36:4181-5.
    PubMed     Text format     Abstract available


  88. KUMASHIRO R, Konishi K, Chiba T, Akahoshi T, et al
    Integrated Endoscopic System Based on Optical Imaging and Hyperspectral Data Analysis for Colorectal Cancer Detection.
    Anticancer Res. 2016;36:3925-32.
    PubMed     Text format     Abstract available


  89. SUETSUGU A, Matsumoto T, Hasegawa K, Nakamura M, et al
    Color-coded Live Imaging of Heterokaryon Formation and Nuclear Fusion of Hybridizing Cancer Cells.
    Anticancer Res. 2016;36:3827-31.
    PubMed     Text format     Abstract available


  90. BUDJAN J, Sauter EA, Morelli JN, Nolden M, et al
    Semi-automatic Volumetric Measurement of Treatment Response in Hepatocellular Carcinoma After Trans-arterial Chemoembolization.
    Anticancer Res. 2016;36:4353-8.
    PubMed     Text format     Abstract available


  91. ZUGOR V, Poth S, Kuhn R, Bernat MM, et al
    Is an Extended Prostate Biopsy Scheme Associated with an Improvement in the Accuracy Between the Biopsy Gleason Score and Radical Prostatectomy Pathology? A Multivariate Analysis.
    Anticancer Res. 2016;36:4285-8.
    PubMed     Text format     Abstract available


  92. FRIEDRICH RE, Nuding MA
    Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Anticancer Res. 2016;36:4095-121.
    PubMed     Text format     Abstract available


  93. TOME Y, Yano S, Sugimoto N, Mii S, et al
    Use of alphav Integrin Linked to Green Fluorescent Protein in Osteosarcoma Cells and Confocal Microscopy to Image Molecular Dynamics During Lung Metastasis in Nude Mice.
    Anticancer Res. 2016;36:3811-6.
    PubMed     Text format     Abstract available


    July 2016
  94. SHIMAMURA Y, Tamatani D, Kuniyasu S, Mizuki Y, et al
    5-Aminolevulinic Acid Enhances Ultrasound-mediated Antitumor Activity via Mitochondrial Oxidative Damage in Breast Cancer.
    Anticancer Res. 2016;36:3607-12.
    PubMed     Text format     Abstract available


  95. YOKOYAMA J, Ishibashi K, Shiramizu H, Ohba S, et al
    Impact of Endoscopic Indocyanine Green Fluorescence Imaging on Superselective Intra-arterial Chemotherapy for Recurrent Cancer of the Skull Base.
    Anticancer Res. 2016;36:3419-24.
    PubMed     Text format     Abstract available


  96. FROSINA G
    Non-routine Tracers for PET Imaging of High-grade Glioma.
    Anticancer Res. 2016;36:3253-60.
    PubMed     Text format     Abstract available


    June 2016
  97. VERNUCCIO F, Taibbi A, Picone D, LA Grutta L, et al
    Imaging of Gastrointestinal Stromal Tumors: From Diagnosis to Evaluation of Therapeutic Response.
    Anticancer Res. 2016;36:2639-48.
    PubMed     Text format     Abstract available


  98. GORKA E, Fabo D, Gezsi A, Czirbesz K, et al
    Distance from Primary Tumor Is the Strongest Predictor for Early Onset of Brain Metastases in Melanoma.
    Anticancer Res. 2016;36:3065-9.
    PubMed     Text format     Abstract available


  99. MIYAMOTO J, Michaud AL, Harandi NK, Kim EJ, et al
    The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning.
    Anticancer Res. 2016;36:3013-7.
    PubMed     Text format     Abstract available


  100. RATHMANN N, Budjan J, Mari F, Grimm R, et al
    Semiautomatic Whole-lesion Apparent Diffusion Coefficient Assessment for Early Prediction of Liver Tumor Response to Radioembolization.
    Anticancer Res. 2016;36:2961-6.
    PubMed     Text format     Abstract available


    May 2016
  101. BACALBASA N, Balescu I, Dragan I, Banceanu G, et al
    Endometrial Adenocarcinoma Presenting as Hematometra with Underlying Thickened Endometrial Lining in a Postmenopausal Woman - A Case Report.
    Anticancer Res. 2016;36:2353-7.
    PubMed     Text format     Abstract available


  102. MA X, Wu YI, Yang X, Yang S, et al
    A Novel 1,2-Dihydroquinoline Anticancer Agent and Its Delivery to Tumor Cells Using Cationic Liposomes.
    Anticancer Res. 2016;36:2105-11.
    PubMed     Text format     Abstract available


    March 2016
  103. GIORGAKIS E, Ramesh B, Kamali-Dashtarzheneh A, Fusai GK, et al
    Demonstration of Calreticulin Expression in Hamster Pancreatic Adenocarcinoma with the Use of Fluorescent Gold Quantum Dots.
    Anticancer Res. 2016;36:861-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diagnostic Imaging is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: